You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 202381 - 202390 of 207712 results
  1. Validation of Point-of-Care Breath Test for Pulmonary TB

    SBC: MENSSANA RESEARCH INC            Topic: NIAID

    DESCRIPTION provided by applicant The problem Active pulmonary tuberculosis TB is a leading cause of death from infectious disease throughout the world Two billion people one third of the worldandapos s population are infected with Mycobacterium tuberculosis and million died from the disease in Sputum microscopy and culture remains the mainstay of laboratory diagnosis accompani ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  2. VALIDATION OF PROSTATE CANCER ONCOGENES

    SBC: Eikos, Inc.            Topic: N/A

    We propose the creation of a comprehensive tissue microarray consisting of all pathologic stages of adenocarcinoma of the prostate as a tool for testing promising cellular markers - genes and proteins that will serve as an aid to researchers in validating the potential usefulness of any given marker. We propose to create this tissue microarray and test its usefulness by observing the differential ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  3. Validation of rapid test kits for foodborne pathogens

    SBC: CELLBAE INC.            Topic: 85

    Early rapid and accurate detection of foodborne pathogens is important for outbreak preventionmaintaining food safety along the supply chain and ensuring that food consignments are notsubjected to unnecessary delays. Confirmatory culture-based methods or technologies (e.g.polymerase chain reaction and mass spectrometry) are labor-intensive have long turnaround time(1-5 days) and require expensive ...

    SBIR Phase I 2023 Department of Agriculture
  4. Validation of Red Blood Cell Mechanical Fragility as a Metric for Assessing Blood Damage Caused by Implantable Ventricular Assist DEvices

    SBC: Blaze Medical Devices            Topic: FDA

    DESCRIPTION provided by applicant Blaze Medical Devices Blaze is developing a rapid integrated test for RBC mechanical fragility MF as a potential indicator of safety and performance of blood handling devices The safety and performance of blood handling devices such as VADs are evaluated by hemocompatibility testing to assess the damage they inflict upon red blood cells RBC The chief in ...

    SBIR Phase I 2015 Department of Health and Human ServicesFood and Drug Administration
  5. Validation of Segmented Flanges for Large Diameter Wind Turbine Towers

    SBC: Keystone Tower Systems, Inc.            Topic: 86

    At sites ranging from Texas to Iowa, utility scale wind has become the lowest cost electricity source available, with recent prices well below 3cents/kWhr, lower than the cost of both coal and shale gas. This not only provides these communities with clean, low cost energy, it also provides a valuable "second crop" to the land owners in these areas. However, this opportunity is currently limited to ...

    SBIR Phase II 2016 Department of Agriculture
  6. VALIDATION OF SERUM BIOASSAY FOR DIOXIN-LIKE TOXICANTS

    SBC: XENOBIOTIC DETECTION SYSTEMS            Topic: N/A

    N/A

    SBIR Phase II 1998 Department of Health and Human Services
  7. VALIDATION OF SERUM BIOASSAY FOR DIOXIN-LIKE TOXICANTS

    SBC: XENOBIOTIC DETECTION SYSTEMS            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  8. VALIDATION OF SHADE A MOBILE TECHNOLOGY FOR MONITORING OF ULTRAVIOLET EXPOSURE

    SBC: YOUV LABS            Topic: NCI

    Shade helps people manage their UV exposure it is a ultraviolet UV monitor with unprecidented accuracyconnected to a mobile application Although it is one of the clearest and most controllable causes of cancer UV exposure can be difficult to estimate due to the importance of combining many rapidly changing factors including intensity shade and use of protective cloting and sunscreen To val ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  9. Validation of ShuntCheck-Micro-Pumper, a non-invasive diagnostic procedure for de

    SBC: NEURODX DEVELOPMENT LLC            Topic: NINDS

    DESCRIPTION (provided by applicant): This Phase 2 SBIR will provide and clinically validate the first portable, non-invasive diagnostic test for differentiating intermittently flowing patent shunts from occluded or partially occluded shunts - ShuntCheck- Micro-Pumper. This device will result in improved clinical management of hydrocephalus by providing a rapid and non-invasive method for detec ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  10. Validation of SPX as a candidate for the treatment of cystic fibrosis

    SBC: SPYRYX LLC            Topic: NHLBI

    The Epithelial Na Channel ENaC is the rate limiting step for Na absorption across many epithelia In the airways of cystic fibrosis CF patients ENaC is abnormally hyperactive leading to disproportionate Na absorption and a depletion of airway surface liquid ASL volume ENaC hyperactivity contributes to mucus stasis and increased incidence of airway infections that frequently lead to the ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government